Stem Cells for End-Stage Liver Disease
Part of Digestive system clinical trials.
This study tests whether stem cells from donated umbilical cords can help people with end-stage liver disease. Doctors want to see if the way the cells are given (like through a vein or artery) affects how well they work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old
- You have end-stage liver disease (severe liver failure)
- You cannot have any tumors in the liver or other organs
- You cannot have serious heart or lung problems
- You cannot be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests whether stem cells (called mesenchymal stem cells) are safe and can help people with a sudden, severe liver failure. You may qualify if your liver is failing quickly and you are not eligible for a transplant.
This trial tests whether injecting special stem cells (called mesenchymal stem cells) can help people with a sudden worsening of chronic liver disease (called acute-on-chronic liver failure) who do not have a virus as the cause. It is for patients who are too sick for standard treatment but who cannot get a liver transplant right away.
This trial tests if infusions of stem cells from donated umbilical cords can help people with a severe type of liver failure caused by hepatitis B. It aims to see if the treatment is safe and can improve liver function.
This trial tests whether stem cells from donated umbilical cords can help people with acute-on-chronic liver failure, a sudden worsening of chronic liver disease. The goal is to see if this treatment improves liver function and survival.
This trial tests whether adding mesenchymal stem cells to a blood-cleaning procedure helps people with acute liver failure recover. It may reduce inflammation and improve liver function.
This early-stage trial tests umbilical cord “mesenchymal” stem cells in people with liver scarring (cirrhosis) that is caused by hepatitis B. It may help improve liver function and related complications, but it is mainly designed to check safety and how well the treatment works.
Hear when a new End-Stage Liver Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.